Ads
related to: ibrance breast cancer drug- MONALEESA-2 Trial
Learn More About KISQALI®
See M2 Safety & Efficacy Info
- MONALEESA-3 Trial
Learn More About KISQALI®
See M3 Safety & Efficacy Info
- Treatment Administration
Read More About Dose Scheduling
See About Treatment Administration
- MONALEESA-7 Trial
Learn More About KISQALI®
See M7 Safety & Efficacy Info
- KISQALI® Video Library
View Informational Videos From
Medical Experts About KISQALI®
- 3 Phase III Trial Info
View Efficacy Information
Data Like You've Never Seen Before
- MONALEESA-2 Trial
Search results
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 6 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
Roche's (RHHBY) Inavolisib NDA Gets FDA Priority Review Tag
Zacks via Yahoo Finance· 11 hours agoThe FDA grants priority review to Roche's (RHHBY) NDA for the inavolisib combination regimen for...
Sanofi (SNY) Ends Development of Breast Cancer Drug, Stock Down
Zacks via Yahoo Finance· 2 years agoShares of Sanofi SNY were down 5.8% in the pre-market trading session on Aug 17, after management...
Novartis Announces Positive Data on Breast Cancer Drug Kisqali
Zacks via Yahoo Finance· 12 months agoNovartis NVS announced positive data on the breast cancer drug Kisqali (ribociclib) from the...
Novartis drug cuts recurrence risk by 25% in early-stage breast cancer
Reuters via Yahoo Finance· 12 months agoNovartis breast cancer drug Kisqali cut the risk of recurrence by more than 25% in a pivotal trial...
What are the latest developments in breast cancer treatment? Central Mass. experts explain
Worcester Telegram & Gazette via Yahoo News· 8 months agoWORCESTER — October is Breast Cancer Awareness Month, and the rate of breast cancer incidence for...
Olema (OLMA) Up on FDA Fast Track Tag for Breast Cancer Drug
Zacks via Yahoo Finance· 2 years agoThe FDA bestows a Fast Track designation to Olema's (OLMA) novel pipeline candidate, OP-1250, for...
Sanofi Ends Development Of Breast Cancer Drug Amcenestrant After Trial Failure
Benzinga via Yahoo Finance· 2 years agoSanofi SA (NASDAQ: SNY) said it would stop further work on breast cancer drug amcenestrant, putting...
Why more women are living with stage 4 breast cancer
The Hill via Yahoo News· 7 months agoWhen Jenny Burkholder, 51, first began feeling chest pain in 2019, she thought it was just the result of a yoga injury. “I went into chaturanga, and I...
What is metastatic breast cancer and why is it so misunderstood?
Yahoo Life· 2 years ago“We need to be very clear and honest about what we die from, and it’s not ‘complications from breast...
Ad
related to: ibrance breast cancer drug